Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	channel activity	ANO9 PIEZO1 ANO1 GRID2 OTOP3 RYR3 SLC12A5 SLC9C1 P2RX6 SCN4A GRIN3A ATP5PD	3.91e-05	525	112	12	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	ANO9 PIEZO1 ANO1 GRID2 OTOP3 RYR3 SLC12A5 SLC9C1 P2RX6 SCN4A GRIN3A ATP5PD	3.99e-05	526	112	12	GO:0022803
GeneOntologyMolecularFunction	monoatomic ion channel activity	ANO9 PIEZO1 ANO1 GRID2 OTOP3 RYR3 SLC9C1 P2RX6 SCN4A GRIN3A ATP5PD	5.47e-05	459	112	11	GO:0005216
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH7 DYNC1H1	1.32e-04	18	112	3	GO:0008569
GeneOntologyMolecularFunction	pantothenate kinase activity	PANK3 PANK2	1.86e-04	4	112	2	GO:0004594
GeneOntologyMolecularFunction	phospholipid scramblase activity	VMP1 ANO9 ANO1	2.80e-04	23	112	3	GO:0017128
GeneOntologyMolecularFunction	actin filament binding	VIL1 FLII MYO10 NEB CORO2B PLEC HCLS1	2.95e-04	227	112	7	GO:0051015
GeneOntologyMolecularFunction	chitinase activity	CHI3L2 OVGP1	4.61e-04	6	112	2	GO:0004568
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DNAH7 DYNC1H1	5.08e-04	28	112	3	GO:0051959
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH10 MYO10 DNAH7 KIF2B DYNC1H1	5.37e-04	118	112	5	GO:0003774
GeneOntologyMolecularFunction	microtubule motor activity	DNAH10 DNAH7 KIF2B DYNC1H1	6.47e-04	70	112	4	GO:0003777
GeneOntologyMolecularFunction	monoatomic cation channel activity	PIEZO1 ANO1 OTOP3 RYR3 P2RX6 SCN4A GRIN3A ATP5PD	7.06e-04	343	112	8	GO:0005261
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	ANO9 ANO1 GRID2 RYR3 P2RX6 GRIN3A	7.73e-04	193	112	6	GO:0015276
GeneOntologyMolecularFunction	chitin binding	CHI3L2 OVGP1	8.54e-04	8	112	2	GO:0008061
GeneOntologyMolecularFunction	ligand-gated channel activity	ANO9 ANO1 GRID2 RYR3 P2RX6 GRIN3A	8.60e-04	197	112	6	GO:0022834
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH10 DNAH7 DYNC1H1	1.16e-03	37	112	3	GO:0045505
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	ANO9 PIEZO1 ANO1 GRID2 OTOP3 RYR3 SLC12A5 SLC9C1 P2RX6 SCN4A GRIN3A ATP5PD	1.65e-03	793	112	12	GO:0015075
GeneOntologyMolecularFunction	structural constituent of muscle	OBSCN NEB PLEC	1.80e-03	43	112	3	GO:0008307
GeneOntologyCellularComponent	postsynaptic specialization membrane	GRID2 CSMD2 CRHR1 SLC12A5 EFNB2 P2RX6 GRIN3A	1.12e-04	201	113	7	GO:0099634
GeneOntologyCellularComponent	azurophil granule	HEXA MAN2B1 ABCA13 PRCP CCT8 DYNC1H1	2.36e-04	160	113	6	GO:0042582
GeneOntologyCellularComponent	primary lysosome	HEXA MAN2B1 ABCA13 PRCP CCT8 DYNC1H1	2.36e-04	160	113	6	GO:0005766
HumanPheno	Type 2 muscle fiber predominance	COQ5 OBSCN DYNC1H1	3.65e-05	9	40	3	HP:0010602
HumanPheno	Abnormal muscle fiber-type distribution	COQ5 OBSCN NEB RYR3 SCN4A DYNC1H1	3.84e-05	83	40	6	HP:0033684
Domain	DM15	LARP1 LARP1B	3.56e-05	2	112	2	SM00684
Domain	DM15	LARP1 LARP1B	3.56e-05	2	112	2	IPR006607
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	PF08393
Domain	MT	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	PF12777
Domain	AAA_8	DNAH10 DNAH7 DYNC1H1	7.28e-05	14	112	3	PF12780
Domain	DHC_fam	DNAH10 DNAH7 DYNC1H1	9.06e-05	15	112	3	IPR026983
Domain	Dynein_heavy	DNAH10 DNAH7 DYNC1H1	9.06e-05	15	112	3	PF03028
Domain	Dynein_heavy_dom	DNAH10 DNAH7 DYNC1H1	9.06e-05	15	112	3	IPR004273
Domain	IQ	LRRIQ3 MYO10 OBSCN ADGB SCN4A	1.26e-04	81	112	5	SM00015
Domain	Fibrinogen_CS	ANGPTL1 ANGPTL2 ANGPTL5	1.90e-04	19	112	3	IPR020837
Domain	IQ_motif_EF-hand-BS	LRRIQ3 MYO10 OBSCN ADGB SCN4A	2.08e-04	90	112	5	IPR000048
Domain	Type_II_PanK	PANK3 PANK2	2.12e-04	4	112	2	IPR004567
Domain	Fumble	PANK3 PANK2	2.12e-04	4	112	2	PF03630
Domain	IQ	LRRIQ3 MYO10 OBSCN ADGB SCN4A	2.42e-04	93	112	5	PS50096
Domain	-	CHI3L2 OVGP1	3.52e-04	5	112	2	3.10.50.10
Domain	Chitinase_insertion	CHI3L2 OVGP1	3.52e-04	5	112	2	IPR029070
Domain	Fibrinogen_a/b/g_C_2	ANGPTL1 ANGPTL2 ANGPTL5	3.88e-04	24	112	3	IPR014715
Domain	-	ANGPTL1 ANGPTL2 ANGPTL5	3.88e-04	24	112	3	4.10.530.10
Domain	Glyco_hydro_18_chit_AS	CHI3L2 OVGP1	5.26e-04	6	112	2	IPR001579
Domain	Fibrinogen_C	ANGPTL1 ANGPTL2 ANGPTL5	5.53e-04	27	112	3	PF00147
Domain	FBG	ANGPTL1 ANGPTL2 ANGPTL5	6.85e-04	29	112	3	SM00186
Domain	Glyco_hydro18_cat	CHI3L2 OVGP1	7.34e-04	7	112	2	IPR001223
Domain	LA	LARP1 LARP1B	7.34e-04	7	112	2	SM00715
Domain	HTH_LA	LARP1 LARP1B	7.34e-04	7	112	2	PS50961
Domain	Glyco_hydro_18	CHI3L2 OVGP1	7.34e-04	7	112	2	PF00704
Domain	Chitinase_II	CHI3L2 OVGP1	7.34e-04	7	112	2	IPR011583
Domain	La	LARP1 LARP1B	7.34e-04	7	112	2	PF05383
Domain	Glyco_18	CHI3L2 OVGP1	7.34e-04	7	112	2	SM00636
Domain	CHITINASE_18	CHI3L2 OVGP1	7.34e-04	7	112	2	PS01095
Domain	Lupus_La_RNA-bd	LARP1 LARP1B	7.34e-04	7	112	2	IPR006630
Domain	-	ANGPTL1 ANGPTL2 ANGPTL5	7.57e-04	30	112	3	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	ANGPTL1 ANGPTL2 ANGPTL5	7.57e-04	30	112	3	IPR014716
Domain	-	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2 VPS41 SEMA3E	8.95e-04	333	112	8	2.130.10.10
Domain	FIBRINOGEN_C_1	ANGPTL1 ANGPTL2 ANGPTL5	9.17e-04	32	112	3	PS00514
Domain	Fibrinogen_a/b/g_C_dom	ANGPTL1 ANGPTL2 ANGPTL5	9.17e-04	32	112	3	IPR002181
Domain	FIBRINOGEN_C_2	ANGPTL1 ANGPTL2 ANGPTL5	9.17e-04	32	112	3	PS51406
Domain	WD40/YVTN_repeat-like_dom	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2 VPS41 SEMA3E	9.30e-04	335	112	8	IPR015943
Domain	Villin/Gelsolin	VIL1 FLII	9.75e-04	8	112	2	IPR007122
Domain	DHC_N1	DNAH10 DYNC1H1	9.75e-04	8	112	2	PF08385
Domain	GEL	VIL1 FLII	9.75e-04	8	112	2	SM00262
Domain	Dynein_heavy_dom-1	DNAH10 DYNC1H1	9.75e-04	8	112	2	IPR013594
Domain	-	HEXA CHI3L2 OVGP1	1.19e-03	35	112	3	3.20.20.80
Domain	PH	MYO10 PLEKHG7 OBSCN PSD3 STAP2 PLD1 ARAP2	1.44e-03	278	112	7	SM00233
Domain	PH_DOMAIN	MYO10 PLEKHG7 OBSCN PSD3 STAP2 PLD1 ARAP2	1.47e-03	279	112	7	PS50003
Domain	PH_domain	MYO10 PLEKHG7 OBSCN PSD3 STAP2 PLD1 ARAP2	1.50e-03	280	112	7	IPR001849
Domain	Glyco_hydro_catalytic_dom	HEXA CHI3L2 OVGP1	1.52e-03	38	112	3	IPR013781
Domain	Leu-rich_rpt_4	FLII LRRIQ3	1.55e-03	10	112	2	IPR025875
Domain	Anoctamin	ANO9 ANO1	1.55e-03	10	112	2	PF04547
Domain	Anoctamin	ANO9 ANO1	1.55e-03	10	112	2	IPR007632
Domain	LRR_4	FLII LRRIQ3	1.55e-03	10	112	2	PF12799
Domain	AAA	DNAH10 ABCA13 DNAH7 ABCA10 DYNC1H1	1.76e-03	144	112	5	SM00382
Domain	AAA+_ATPase	DNAH10 ABCA13 DNAH7 ABCA10 DYNC1H1	1.76e-03	144	112	5	IPR003593
Domain	WD40_repeat_dom	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2 VPS41	2.09e-03	297	112	7	IPR017986
Domain	ABC_A	ABCA13 ABCA10	2.26e-03	12	112	2	IPR026082
Domain	Gelsolin	VIL1 FLII	3.09e-03	14	112	2	PF00626
Domain	Gelsolin-like_dom	VIL1 FLII	3.09e-03	14	112	2	IPR007123
Domain	ATPase_dyneun-rel_AAA	DNAH10 DYNC1H1	3.09e-03	14	112	2	IPR011704
Domain	Anticodon-bd	RPF1 POLG2	3.09e-03	14	112	2	IPR004154
Domain	AAA_5	DNAH10 DYNC1H1	3.09e-03	14	112	2	PF07728
Domain	Glycoside_hydrolase_SF	HEXA CHI3L2 OVGP1	3.95e-03	53	112	3	IPR017853
Domain	PH_dom-like	MYO10 PLEKHG7 OBSCN PSD3 STAP2 NBEAL2 PLD1 ARAP2	4.14e-03	426	112	8	IPR011993
Domain	WD40	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2	4.72e-03	259	112	6	PF00400
Domain	aa-tRNA-synth_I_CS	IARS1 YARS1	5.12e-03	18	112	2	IPR001412
Domain	Rib_L2_dom2	UHRF1 TP53BP1	5.12e-03	18	112	2	IPR014722
Domain	Lig_chan-Glu_bd	GRID2 GRIN3A	5.12e-03	18	112	2	PF10613
Domain	Glu/Gly-bd	GRID2 GRIN3A	5.12e-03	18	112	2	IPR019594
Domain	Lig_chan-Glu_bd	GRID2 GRIN3A	5.12e-03	18	112	2	SM00918
Domain	Iontro_rcpt	GRID2 GRIN3A	5.12e-03	18	112	2	IPR001320
Domain	Iono_rcpt_met	GRID2 GRIN3A	5.12e-03	18	112	2	IPR001508
Domain	-	UHRF1 TP53BP1	5.12e-03	18	112	2	2.30.30.30
Domain	Lig_chan	GRID2 GRIN3A	5.12e-03	18	112	2	PF00060
Domain	PBPe	GRID2 GRIN3A	5.12e-03	18	112	2	SM00079
Domain	WD40	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2	5.56e-03	268	112	6	SM00320
Domain	AA_TRNA_LIGASE_I	IARS1 YARS1	5.70e-03	19	112	2	PS00178
Domain	WD40_repeat	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2	5.97e-03	272	112	6	IPR001680
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HEXA VMP1 MOSPD2 TMEM248 MAN2B1 COPA MYCBP2 PIEZO1 LANCL1 H6PD NCAPG2 KLHL11 PRCP SCARB1 EBP CCT8 UHRF1 LRP6 ATP5PD	1.32e-08	1201	114	19	35696571
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	HEXA MAN2B1 COPA IARS1 YARS1 CCT8 PLEC DYNC1H1 HCLS1 TP53BP1	2.15e-07	344	114	10	30333137
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	HEXA MAN2B1 COPA MYCBP2 IARS1 LARP1 LANCL1 OAT YARS1 METTL13 PRCP SCARB1 EBP CCT8 ATP5PD DYNC1H1 TP53BP1	1.15e-06	1297	114	17	33545068
Pubmed	Identification of a novel human angiopoietin-like gene expressed mainly in heart.	ANGPTL1 ANGPTL2 ANGPTL5	4.05e-06	10	114	3	12624729
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PANK3 MYCBP2 STXBP4 PSD3 LARP1 LARP1B DNAH7 WDR59 PANK2 CLK3 PLEC EDRF1 ARAP2	5.21e-06	861	114	13	36931259
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MYCBP2 IARS1 IFT172 LARP1 NCAPG2 EFHC2 SETDB1 SLC9C1 PANK2 EBP SCO1 PLEC ATP5PD EDRF1 DYNC1H1 TP53BP1	6.66e-06	1321	114	16	27173435
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	FLII COPA IARS1 LANCL1 TRIM5 CCT8 PLEC CDH3 ATP5PD DYNC1H1 TP53BP1	9.66e-06	647	114	11	26618866
Pubmed	Aberrant expression of angiopoietin-like proteins 1 and 2 in cumulus cells is potentially associated with impaired oocyte developmental competence in polycystic ovary syndrome.	ANGPTL1 ANGPTL2	1.07e-05	2	114	2	26829602
Pubmed	DNA damage response in CD133 + stem/progenitor cells from umbilical cord blood: low level of endogenous foci and high recruitment of 53BP1.	PROM1 TP53BP1	1.07e-05	2	114	2	23206244
Pubmed	UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP.	TXNIP UHRF1	1.07e-05	2	114	2	31043707
Pubmed	Matrix metalloproteinase-9 leads to claudin-5 degradation via the NF-κB pathway in BALB/c mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis.	CLDN5 MMP9	1.07e-05	2	114	2	23505411
Pubmed	Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.	CSMD2 CSMD1	1.07e-05	2	114	2	24408017
Pubmed	Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting.	ANGPTL1 ANGPTL2	1.07e-05	2	114	2	10473614
Pubmed	Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.	TRIM5 DYNC1H1	1.07e-05	2	114	2	24600008
Pubmed	UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer.	TXNIP UHRF1	1.07e-05	2	114	2	33795533
Pubmed	A genetic association study of CSMD1 and CSMD2 with cognitive function.	CSMD2 CSMD1	1.07e-05	2	114	2	27890662
Pubmed	The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.	CSMD2 CSMD1	1.07e-05	2	114	2	21439553
Pubmed	Conditional Deletion of Cytoplasmic Dynein Heavy Chain in Postnatal Photoreceptors.	PROM1 DYNC1H1	1.07e-05	2	114	2	34807236
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH10 DNAH7 DYNC1H1	1.22e-05	14	114	3	9373155
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	VIL1 FLII COPA IARS1 LARP1 OAT YARS1 CCT8 PLEC ATP5PD DYNC1H1	2.31e-05	711	114	11	33022573
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	MYCBP2 CSMD2 IL22RA1 P2RX6 UNC13C CSMD1 MPPED2	2.83e-05	265	114	7	19240061
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	FLII COPA IARS1 LARP1 TXNIP NAMPT UHRF1 PLEC ATP5PD DYNC1H1	3.00e-05	601	114	10	33658012
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD1	3.19e-05	3	114	2	12906867
Pubmed	Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.	NAMPT MMP9	3.19e-05	3	114	2	27224551
Pubmed	RhoA mediates the expression of acidic extracellular pH-induced matrix metalloproteinase-9 mRNA through phospholipase D1 in mouse metastatic B16-BL6 melanoma cells.	PLD1 MMP9	3.19e-05	3	114	2	26782071
Pubmed	Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.	PANK3 PANK2	3.19e-05	3	114	2	17379144
Pubmed	Activation of Endogenous Retroviruses in Dnmt1(-/-) ESCs Involves Disruption of SETDB1-Mediated Repression by NP95 Binding to Hemimethylated DNA.	SETDB1 UHRF1	3.19e-05	3	114	2	27151458
Pubmed	Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5.	CLDN5 MMP9	3.19e-05	3	114	2	25812799
Pubmed	TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.	CLDN5 MMP9	3.19e-05	3	114	2	26006017
Pubmed	Maintenance DNA methylation in pre-meiotic germ cells regulates meiotic prophase by facilitating homologous chromosome pairing.	SETDB1 UHRF1	3.19e-05	3	114	2	33998651
Pubmed	Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder.	PANK3 PANK2	3.19e-05	3	114	2	17631502
Pubmed	Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure.	CLDN5 MMP9	3.19e-05	3	114	2	19821483
Pubmed	Compartmentalization of mammalian pantothenate kinases.	PANK3 PANK2	3.19e-05	3	114	2	23152917
Pubmed	Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1.	PIEZO1 CRHR1	3.19e-05	3	114	2	28698554
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 MYO10 IFT172 PSD3 SLC12A5 SETDB1 DYNC1H1 ARAP2	6.14e-05	407	114	8	12693553
Pubmed	Downregulation of the FBXO43 gene inhibits tumor growth in human breast cancer by limiting its interaction with PCNA.	NAMPT CCT8 PLEC DYNC1H1	6.35e-05	65	114	4	34645483
Pubmed	Germline deletion of pantothenate kinases 1 and 2 reveals the key roles for CoA in postnatal metabolism.	PANK3 PANK2	6.36e-05	4	114	2	22815849
Pubmed	Coenzyme A metabolism.	PANK3 PANK2	6.36e-05	4	114	2	2981478
Pubmed	EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.	EFNB2 CLDN5	6.36e-05	4	114	2	32897857
Pubmed	A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.	PANK3 PANK2	6.36e-05	4	114	2	11479594
Pubmed	A motif in LILRB2 critical for Angptl2 binding and activation.	ANGPTL2 ANGPTL5	6.36e-05	4	114	2	24899623
Pubmed	Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.	PROM1 ANGPTL5	6.36e-05	4	114	2	21559522
Pubmed	CFTR and TMEM16A are separate but functionally related Cl- channels.	ANO9 ANO1	6.36e-05	4	114	2	22178883
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	FLII FLYWCH1 COPA MYO10 IARS1 LARP1 METTL13 CLK3 CCT8 UHRF1 PLEC DYNC1H1	6.86e-05	949	114	12	36574265
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	FLII COPA MYCBP2 IFT172 OAT WDR59 TRIM5 YARS1 RYR3 SETDB1 CORO2B PLEC MPPED2 DYNC1H1	8.23e-05	1285	114	14	35914814
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	COPA IARS1 NBEAL2 SCARB1 EBP CCT8 ATP5PD	9.28e-05	320	114	7	28685749
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	MYO10 OAT GRID2 OTOP3	9.49e-05	72	114	4	25917818
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	COPA IARS1 OAT METTL13 NAMPT CLK3 SCO1 CCT8 DYNC1H1	1.06e-04	565	114	9	33567341
Pubmed	Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.	CLDN5 MMP9	1.06e-04	5	114	2	21857898
Pubmed	Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination.	IARS1 NAMPT DYNC1H1	1.06e-04	28	114	3	35227662
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	VMP1 COPA MYO10 IARS1 LARP1 PLEC DYNC1H1	1.17e-04	332	114	7	37433992
Pubmed	Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.	IFT172 OAT PROM1 NAMPT PANK2 GUCA1A	1.24e-04	233	114	6	32290105
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	FLII COPA MYO10 IARS1 LARP1 OAT CCT8 PLEC DYNC1H1	1.29e-04	580	114	9	35676659
Pubmed	Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase.	COPA MYCBP2 IARS1 KLHL11	1.36e-04	79	114	4	29121065
Pubmed	Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.	HEXA MAN2B1 MMP9	1.44e-04	31	114	3	25645918
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	VIL1 MYO10 ANO1 NEB PLEC	1.49e-04	152	114	5	34299191
Pubmed	Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism.	DNAH10 LANCL1 NAMPT UHRF1	1.50e-04	81	114	4	32060556
Pubmed	Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.	LARP1 LARP1B CCT8 DYNC1H1	1.57e-04	82	114	4	30274258
Pubmed	Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.	NBEAL2 PLD1	1.58e-04	6	114	2	26916731
Pubmed	Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans.	SLC12A5 MMP9	1.58e-04	6	114	2	20650312
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VIL1 FLII COPA LARP1 LARP1B METTL13 NAMPT EBP CCT8 UHRF1 PLD1 PLEC POLG2 DYNC1H1	1.62e-04	1371	114	14	36244648
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYCBP2 IARS1 LARP1 PANK2 CLK3 PLD1 DYNC1H1	1.85e-04	358	114	7	32460013
Pubmed	Genome-wide association study of antibody response to smallpox vaccine.	ZNF732 UNC13C CSMD1	1.91e-04	34	114	3	22542470
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLII IARS1 LARP1 YARS1 PLEC DYNC1H1 TP53BP1	1.91e-04	360	114	7	33111431
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HEXA MAN2B1 COPA IARS1 OAT H6PD PRCP SCARB1 CCT8	1.94e-04	613	114	9	22268729
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	PANK3 IL22RA1 YARS1 KIF2B NBEAL2 MMP9 DYNC1H1	1.95e-04	361	114	7	18976975
Pubmed	Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.	NAMPT HCLS1	2.21e-04	7	114	2	23001182
Pubmed	Genetic analysis of intestinal cholesterol absorption in inbred mice.	CYP27A1 SCARB1	2.21e-04	7	114	2	11714849
Pubmed	Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.	CLDN5 MMP9	2.21e-04	7	114	2	21641584
Pubmed	Amotl2 interacts with LL5β, localizes to podosomes and regulates postsynaptic differentiation in muscle.	FLII PLEC	2.21e-04	7	114	2	23525008
Pubmed	Angiopoietin-like gene expression in the mouse uterus during implantation and in response to steroids.	ANGPTL1 ANGPTL2	2.21e-04	7	114	2	22350948
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLII COPA DNAH10 IARS1 LARP1 LANCL1 OAT YARS1 METTL13 NAMPT CCT8 UHRF1 MMP9 DYNC1H1	2.41e-04	1425	114	14	30948266
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	FLII COPA IARS1 CCT8 PLEC DYNC1H1	2.63e-04	268	114	6	33024031
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	COPA IARS1 LARP1 OAT YARS1 NAMPT CCT8 PLEC ATP5PD DYNC1H1	2.70e-04	786	114	10	29128334
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	COPA IARS1 LARP1 OAT YARS1 NAMPT CCT8	2.79e-04	383	114	7	29331416
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HEXA FLII MAN2B1 MYCBP2 MYO10 PIEZO1 OBSCN WDR59 NBEAL2 SCARB1 PLEC DYNC1H1	2.81e-04	1105	114	12	35748872
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	COPA MYCBP2 IARS1 CCT8 DYNC1H1	2.87e-04	175	114	5	25756610
Pubmed	The anoctamin family: TMEM16A and TMEM16B as calcium-activated chloride channels.	ANO9 ANO1	2.94e-04	8	114	2	21984732
Pubmed	Expression and function of epithelial anoctamins.	ANO9 ANO1	2.94e-04	8	114	2	20056604
Pubmed	Expression of TMEM16 paralogs during murine embryogenesis.	ANO9 ANO1	2.94e-04	8	114	2	18729231
Pubmed	HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.	CLDN5 MMP9	2.94e-04	8	114	2	22591361
Pubmed	Anoctamins are a family of Ca2+-activated Cl- channels.	ANO9 ANO1	2.94e-04	8	114	2	22946059
Pubmed	Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.	ANGPTL2 ANGPTL5	2.94e-04	8	114	2	22660330
Pubmed	A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus.	VIL1 NEB	2.94e-04	8	114	2	1970800
Pubmed	Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-/- embryos at 12.5 to 14.5 days of gestation.	SCARB1 LRP6	2.94e-04	8	114	2	15265030
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	COPA MYCBP2 IARS1 LARP1 LANCL1 YARS1 CLK3 CCT8 PLEC DYNC1H1	3.39e-04	809	114	10	32129710
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	COPA LARP1 LANCL1 PLEC DYNC1H1	3.44e-04	182	114	5	31067453
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	COPA IARS1 OAT YARS1 CCT8 PLEC DYNC1H1	3.46e-04	397	114	7	21319273
Pubmed	Proteomic identification of brain proteins that interact with dynein light chain LC8.	MYO10 GRIN3A DYNC1H1	3.59e-04	42	114	3	14760703
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	FLII ABCA13 RYR3 ASB5 PLEC DYNC1H1	3.59e-04	284	114	6	29459677
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MOSPD2 MYCBP2 DNAJC25 COQ5 STXBP4 PIEZO1 PSD3 OAT NCAPG2 EFNB2 SCO1 ATP5PD EDRF1 TP53BP1	3.70e-04	1487	114	14	33957083
Pubmed	ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking.	PSD3 TP53BP1	3.78e-04	9	114	2	21275903
Pubmed	Spontaneous and induced mouse mutations with cerebellar dysfunctions: behavior and neurochemistry.	GRID2 UNC13C	3.78e-04	9	114	2	16499884
Pubmed	Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion.	EFNB2 MMP9	3.78e-04	9	114	2	18713744
Pubmed	Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.	CHI3L2 ANGPTL1 PLD1 SEMA3E	4.06e-04	105	114	4	24667918
Pubmed	Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.	WDR5B MYCBP2 LRP6	4.12e-04	44	114	3	22645275
Pubmed	Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy.	RPF1 COQ5 OAT TRIM5 KLHL11 NAMPT	4.16e-04	292	114	6	35545034
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	FLII IARS1 CCT8 PLEC DYNC1H1	4.29e-04	191	114	5	33762435
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	VIL1 FLII PLEC	4.40e-04	45	114	3	22114352
Pubmed	Effect of weight loss on proinflammatory state of mononuclear cells in obese women.	NAMPT MMP9	4.71e-04	10	114	2	18356846
GeneFamily	Fibrinogen C domain containing\|Angiopoietin like	ANGPTL1 ANGPTL2 ANGPTL5	6.13e-06	8	88	3	905
GeneFamily	Fibrinogen C domain containing	ANGPTL1 ANGPTL2 ANGPTL5	2.37e-04	25	88	3	554
GeneFamily	Chitinases	CHI3L2 OVGP1	4.84e-04	7	88	2	816
GeneFamily	La ribonucleoprotein domain containing\|RNA binding motif containing	LARP1 LARP1B	4.84e-04	7	88	2	625
GeneFamily	Gelsolin/villins	VIL1 FLII	6.43e-04	8	88	2	950
GeneFamily	Tudor domain containing	SETDB1 UHRF1 TP53BP1	7.68e-04	37	88	3	780
GeneFamily	Anoctamins	ANO9 ANO1	1.03e-03	10	88	2	865
GeneFamily	WD repeat domain containing	WDR5B COPA IFT172 WDR59 CORO2B NBEAL2	1.76e-03	262	88	6	362
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA10	2.05e-03	14	88	2	805
GeneFamily	Dyneins, axonemal	DNAH10 DNAH7	3.04e-03	17	88	2	536
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	MYO10 PLEKHG7 PSD3 PLD1 ARAP2	3.33e-03	206	88	5	682
GeneFamily	Aminoacyl tRNA synthetases, Class I	IARS1 YARS1	3.80e-03	19	88	2	131
GeneFamily	EF-hand domain containing	CALML6 DNAH7 RYR3 EFHC2 GUCA1A	4.32e-03	219	88	5	863
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2 PROM1	3.15e-08	189	114	8	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 IFT172 CDHR3 DNAH7 ADGB EFHC2 PROM1	4.34e-08	197	114	8	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 IFT172 CDHR3 DNAH7 ADGB EFHC2 PROM1	4.34e-08	197	114	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 IFT172 CDHR3 DNAH7 ADGB EFHC2 PROM1	4.34e-08	197	114	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 IFT172 CDHR3 DNAH7 ADGB EFHC2 PROM1	4.34e-08	197	114	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	(02)_MMP9/10+-(1)_GFP\|(02)_MMP9/10+ / shred by cell type by condition	PIEZO1 ANO1 TXNIP CORO2B EFNB2 PLEC MMP9 CDH3	4.69e-08	199	114	8	448ba982be804007f991d469eca9d885b21ae499
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB PROM1	2.73e-07	169	114	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 PLEKHG7 IFT172 CDHR3 DNAH7 ADGB FER1L5	3.60e-07	176	114	7	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	4.51e-07	182	114	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 ABCA13 OBSCN NEB RYR3 UNC13C CSMD1	4.86e-07	184	114	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 ABCA13 OBSCN NEB RYR3 UNC13C CSMD1	4.86e-07	184	114	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 ABCA13 OBSCN NEB RYR3 UNC13C CSMD1	4.86e-07	184	114	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	5.04e-07	185	114	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2 PROM1	5.41e-07	187	114	7	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	5.61e-07	188	114	7	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	5.82e-07	189	114	7	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	5.82e-07	189	114	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	6.24e-07	191	114	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	6.24e-07	191	114	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	6.24e-07	191	114	7	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	6.46e-07	192	114	7	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	6.69e-07	193	114	7	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB PROM1	7.17e-07	195	114	7	79dc031258579ea328181dda33710dd897f1064a
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2 PROM1	7.17e-07	195	114	7	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 IFT172 CDHR3 DNAH7 ADGB EFHC2 PROM1	7.17e-07	195	114	7	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 PLEKHG7 IFT172 CDHR3 DNAH7 EFHC2 PROM1	7.95e-07	198	114	7	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.22e-07	199	114	7	2498237b9e895ca4826a3378d9d40989968df72b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.22e-07	199	114	7	542ec45c931b40738df1f3777b00c83be33a514a
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.50e-07	200	114	7	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.50e-07	200	114	7	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NAMPT ASB5 CSMD1 MMP9 CDH3 SEMA3E	2.37e-06	149	114	6	c5eedb54ef2e0f131aa6730612c921bc19479632
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NAMPT ASB5 CSMD1 MMP9 CDH3 SEMA3E	2.37e-06	149	114	6	a22417286de8606f0cc94f86b70bce17aeefb9c2
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	WDR5B PLEKHG7 CDHR3 ADGB EFHC2 PROM1	4.74e-06	168	114	6	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GRID2 NEB RYR3 ASB5 UNC13C CSMD1	5.24e-06	171	114	6	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 PLEKHG7 CDHR3 DNAH7 PROM1	5.60e-06	173	114	6	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIEZO1 PSD3 CORO2B UNC13C ZNF98 MPPED2	6.81e-06	179	114	6	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CLEC9A EFNB2 SCARB1 CLDN5 MPPED2 ARAP2	7.26e-06	181	114	6	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	7.26e-06	181	114	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	7.97e-06	184	114	6	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 CDHR3 DNAH7 ADGB PROM1 CORO2B	8.22e-06	185	114	6	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB PROM1	8.22e-06	185	114	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.22e-06	185	114	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	8.48e-06	186	114	6	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	8.74e-06	187	114	6	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB EFHC2	8.74e-06	187	114	6	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	9.01e-06	188	114	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	9.01e-06	188	114	6	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	9.29e-06	189	114	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH10 PLEKHG7 CDHR3 DNAH7 ADGB PROM1	9.29e-06	189	114	6	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	9.29e-06	189	114	6	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	Ciliated\|World / shred by cell class for parenchyma	DNAH10 CDHR3 DNAH7 ADGB EFHC2 PROM1	9.29e-06	189	114	6	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	9.86e-06	191	114	6	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	9.86e-06	191	114	6	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 RYR3 PROM1	9.86e-06	191	114	6	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	9.86e-06	191	114	6	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	9.86e-06	191	114	6	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	9.86e-06	191	114	6	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 RYR3 PROM1	9.86e-06	191	114	6	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	ABCA13 IFT172 CDHR3 PSD3 DNAH7 ADGB	1.02e-05	192	114	6	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	1.05e-05	193	114	6	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB SLC9C1	1.08e-05	194	114	6	958e648138676d46698090b4046cb484083ae449
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.08e-05	194	114	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.08e-05	194	114	6	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.11e-05	195	114	6	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 CSMD2 RYR3 NAMPT CSMD1 MMP9	1.11e-05	195	114	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 CDHR3 NPSR1 DNAH7 ADGB PROM1	1.11e-05	195	114	6	e525b69145059b66417589601f7109af63730f3a
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 CSMD2 RYR3 NAMPT CSMD1 MMP9	1.11e-05	195	114	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	distal-Epithelial-Proximal_Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRIQ3 ABCA13 CDHR3 DNAH7 EFHC2 PROM1	1.11e-05	195	114	6	abe7998421dc59bdae35c0c2251c4a1ebef5e021
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.11e-05	195	114	6	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.11e-05	195	114	6	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	distal-Epithelial-Proximal_Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRIQ3 ABCA13 CDHR3 DNAH7 EFHC2 PROM1	1.11e-05	195	114	6	0e3f74e0877d33c11f048b9be8394596cf5c9c4c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 PLEKHG7 CDHR3 DNAH7 ADGB PROM1	1.11e-05	195	114	6	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	distal-3-Epithelial-Proximal_Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRIQ3 ABCA13 CDHR3 DNAH7 EFHC2 PROM1	1.18e-05	197	114	6	15b4d1203943ce90a7083178d4a4284d9b323071
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	DNAH10 PLEKHG7 DNAH7 ADGB UHRF1 SEMA3E	1.21e-05	198	114	6	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	distal-Epithelial-Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ABCA13 IFT172 CDHR3 DNAH7 PROM1	1.25e-05	199	114	6	6ce0df4a6f4d9353919e26ffab97c9ec89911da6
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 CDHR3 DNAH7 ADGB EFHC2 PROM1	1.28e-05	200	114	6	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH10 PLEKHG7 DNAH7 ADGB PROM1 P2RX6	1.28e-05	200	114	6	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.28e-05	200	114	6	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	DNAJC25 NEB ANGPTL1 EFHC2 PROM1 EFNB2	1.28e-05	200	114	6	98a994692440cb4f505b050276f0c8022c814a21
ToppCell	Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.28e-05	200	114	6	a552a99f5e4fa00dfb7775e5a3e1f62f1530d104
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.28e-05	200	114	6	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Ciliated\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.28e-05	200	114	6	d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	1.28e-05	200	114	6	ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	DNAJC25 NEB ANGPTL1 EFHC2 PROM1 EFNB2	1.28e-05	200	114	6	ef222dc4a205d670172dae74990bdb952ac92e5b
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Ciliated\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	1.28e-05	200	114	6	a521cf837cadf280505ff9d7e641a205af7d6513
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB EFHC2	1.28e-05	200	114	6	918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB PROM1	1.28e-05	200	114	6	cf59110547cc66b5f4a2999735336b0309ba9b0d
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocye.Tnr.Ctps_(Ctps)\|Striatum / BrainAtlas - Mouse McCarroll V32	LRRIQ3 TRIM5 PROM1 ASB5 POLG2	2.46e-05	134	114	5	bc550d3b44f1e1e1c18971c110e816bcffd79d14
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr\|Striatum / BrainAtlas - Mouse McCarroll V32	LRRIQ3 TRIM5 PROM1 ASB5 POLG2	2.46e-05	134	114	5	90a34ae53a602a92f6f998e7cf061d8f4f0da527
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-2\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	PIEZO1 CHI3L2 CRHR1 UNC13C HCLS1	3.59e-05	145	114	5	f9aa7f2401e26f1e8cec1112a71c16e1c2784893
ToppCell	Healthy-CD4+_T_activated\|Healthy / disease group, cell group and cell class	ANO9 STAP2 NCAPG2 SLC12A5 GRIN3A	3.59e-05	145	114	5	45e8089fdf7d6f69b383816d8945e39fba24c873
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH10 ABCA13 CDHR3 DNAH7 ADGB	4.36e-05	151	114	5	8216462e723fec2797387929dde095370947e10a
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	PSD3 CALML6 UHRF1 ZNF98 MPPED2	4.79e-05	154	114	5	8a8c3851888ab86ca2b13ccc042cde1fef8d88f8
ToppCell	control-B_cell\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	VIL1 MYO10 SLC12A5 SLC9C1 CLDN5	5.25e-05	157	114	5	1269b55f2ef6a493f6116b131cc5cc7b8897d63e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA13 NPSR1 OBSCN CHI3L2 CRHR1	5.41e-05	158	114	5	35f3082109a5930b89d14db3c8fa93148d3a5dd4
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CLEC9A MAN2B1 TRIM5 GUCA1A HCLS1	6.09e-05	162	114	5	388670cf3acef17df971c0d8ae3ce14398945192
ToppCell	droplet-Mammary_Gland-nan-18m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXA MAN2B1 PRCP MMP9 HCLS1	6.09e-05	162	114	5	59147406c28b7cdf43a1815f99c15c2bd6ae8fa3
ToppCell	droplet-Mammary_Gland-nan-18m-Myeloid\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXA MAN2B1 PRCP MMP9 HCLS1	6.09e-05	162	114	5	8e0bcc23c3086fc4b0c9dbeec13a7edaf6b83750
ToppCell	droplet-Fat-Gat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A MAN2B1 PRCP MMP9 HCLS1	6.09e-05	162	114	5	052f797d8bcab8fc6a43e0bffdd215c88ee12889
ToppCell	droplet-Mammary_Gland-nan-18m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXA MAN2B1 PRCP MMP9 HCLS1	6.09e-05	162	114	5	736fdcbd0f7d50fc297f13d36ab4c0dc82ad509c
Disease	amino acid measurement	LVRN NPSR1 PSD3 LARP1 DNAH7 RYR3 KIF2B SCN4A UNC13C CSMD1 TRAV13-2	6.06e-05	678	113	11	EFO_0005134
Disease	free cholesterol to total lipids in large HDL percentage	TRIM5 SLC12A5 SCARB1 MMP9	6.42e-05	56	113	4	EFO_0022279
Disease	very low density lipoprotein cholesterol measurement	ZHX3 DNAH10 PSD3 ABCA10 TRIM5 SCARB1 TP53BP1	6.64e-05	260	113	7	EFO_0008317
Disease	pantothenate kinase-associated neurodegeneration (implicated_via_orthology)	PANK3 PANK2	8.68e-05	4	113	2	DOID:3981 (implicated_via_orthology)
Disease	Schizophrenia	ABCA13 NPSR1 PSD3 CSMD2 SLC12A5 SETDB1 PANK2 EFNB2 CLDN5 GRIN3A CSMD1 MMP9	1.49e-04	883	113	12	C0036341
Disease	retinal degeneration (implicated_via_orthology)	IFT172 PROM1 SCO1	2.74e-04	33	113	3	DOID:8466 (implicated_via_orthology)
Disease	coronary aneurysm	CSMD2 GRIN3A CSMD1	3.27e-04	35	113	3	EFO_1000881
Disease	Colorectal Carcinoma	ABCA13 OBSCN GRID2 ABCA10 SLC12A5 PROM1 NAMPT CORO2B OVGP1 EDRF1	3.75e-04	702	113	10	C0009402
Disease	irritable bowel syndrome (biomarker_via_orthology)	CRHR1 EFNB2	4.01e-04	8	113	2	DOID:9778 (biomarker_via_orthology)
Disease	cholesteryl ester measurement	DNAH10 PSD3 ABCA10 TRIM5 SCARB1 TP53BP1	4.78e-04	257	113	6	EFO_0010351
Disease	lipoprotein-associated phospholipase A(2) measurement	VMP1 SCARB1 TP53BP1	4.87e-04	40	113	3	EFO_0004746
Disease	response to lamotrigine	GRIN3A CSMD1	5.14e-04	9	113	2	EFO_0007661
Disease	postburn hypertrophic scarring severity measurement	CSMD1 ARAP2	6.41e-04	10	113	2	EFO_0007747
Disease	malaria	IARS1 OAT SCO1 CSMD1	6.49e-04	102	113	4	EFO_0001068
Disease	peptidyl-glycine alpha-amidating monooxygenase measurement	LVRN MYCBP2	7.82e-04	11	113	2	EFO_0801871
Disease	Congenital myopathy (disorder)	NEB SCN4A	9.36e-04	12	113	2	C0270960
Disease	phospholipids in very small VLDL measurement	ABCA10 TRIM5 TP53BP1	9.96e-04	51	113	3	EFO_0022300
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	PSD3 TRIM5 SCARB1 MMP9 CDH3 TP53BP1	1.20e-03	307	113	6	EFO_0004612, EFO_0020946
Disease	antisaccade response measurement	UNC13C PLEC CSMD1	1.31e-03	56	113	3	EFO_0006874
Disease	Disorder of eye	CYP27A1 OAT PROM1 GUCA1A CDH3	1.37e-03	212	113	5	C0015397
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	DNAH10 LANCL1 TRIM5 SCARB1 MMP9 TP53BP1	1.37e-03	315	113	6	EFO_0004612, EFO_0008591
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	ZHX3 DNAH10 PSD3 TRIM5 TP53BP1	1.45e-03	215	113	5	EFO_0008317, EFO_0008591
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	DNAH10 PSD3 LANCL1 TRIM5 SCARB1 MMP9	1.51e-03	321	113	6	EFO_0004612, EFO_0004639
Disease	cholesteryl esters to total lipids in large HDL percentage	PSD3 SCARB1 TP53BP1	1.52e-03	59	113	3	EFO_0022248
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	ZHX3 DNAH10 PSD3 TRIM5 TP53BP1	1.61e-03	220	113	5	EFO_0004529, EFO_0008317
Disease	cathepsin L1 measurement	MAN2B1 ADGB	1.68e-03	16	113	2	EFO_0010619
Disease	lipid measurement, high density lipoprotein cholesterol measurement	DNAH10 PSD3 LANCL1 TRIM5 SCARB1 MMP9	1.73e-03	330	113	6	EFO_0004529, EFO_0004612
Disease	free cholesterol in very large HDL measurement	SLC12A5 SCARB1 MMP9	1.75e-03	62	113	3	EFO_0022273
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	ZHX3 DNAH10 PSD3 TRIM5 TP53BP1	1.78e-03	225	113	5	EFO_0008317, EFO_0010351
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	ZHX3 DNAH10 PSD3 TRIM5 TP53BP1	1.92e-03	229	113	5	EFO_0004639, EFO_0008317
Disease	pulmonary hypertension (is_marker_for)	NAMPT MMP9 TP53BP1	1.92e-03	64	113	3	DOID:6432 (is_marker_for)
Disease	response to methotrexate, juvenile idiopathic arthritis	CSMD1 ANGPTL5	2.38e-03	19	113	2	EFO_0002609, GO_0031427
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	DNAH10 PSD3 SCARB1 CDH3 TP53BP1	2.48e-03	243	113	5	EFO_0004612, EFO_0020944
Disease	amyloid-beta measurement	FLYWCH1 NPSR1 ABCA10 TRIM5 SCARB1 CSMD1	2.50e-03	355	113	6	EFO_0005194
Disease	S-6-hydroxywarfarin measurement	OAT GRID2 IZUMO3 PROM1 GRIN3A SEMA3E	2.98e-03	368	113	6	EFO_0803326
Disease	Glioblastoma	PROM1 MMP9 TP53BP1	3.50e-03	79	113	3	C0017636
Disease	epilepsy (implicated_via_orthology)	SLC12A5 SCN4A UNC13C DYNC1H1	3.62e-03	163	113	4	DOID:1826 (implicated_via_orthology)
Disease	mosaic loss of chromosome Y measurement	STXBP4 NCAPG2 ANGPTL2	3.63e-03	80	113	3	EFO_0007783
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR3 NAMPT MMP9	3.63e-03	80	113	3	DOID:6432 (biomarker_via_orthology)
Disease	Asthma	CDHR3 NPSR1 MMP9	3.63e-03	80	113	3	C0004096
Disease	Anhedonia	CRHR1 SETDB1	3.80e-03	24	113	2	C0178417
Disease	Myasthenic Syndromes, Congenital	SCN4A PLEC	3.80e-03	24	113	2	C0751882
Disease	airway responsiveness measurement	SOBP CSMD1	3.80e-03	24	113	2	EFO_0006897

Protein segments in the cluster

Peptide	Gene	Start	Entry
GYSDGYTKWDKLKLF	USP26	271	Q9BXU7
SLWKGYYEYLGKRQP	CSMD1	3356	Q96PZ7
DVFAKNSLWKGAYEY	CSMD2	3271	Q7Z408
IFCYLAKYWLKGFVA	ABCA10	76	Q8WWZ4
VWKIFNGGILSNYFK	ADGB	146	Q8N7X0
AIDWAYYKANVAKAG	ATP5PD	51	O75947
KQKYFYKGGLVWDEN	CLK3	551	P49761
LEKYLGGLFVLTKYW	ABCA13	2886	Q86UQ4
ENYKKGFGNIDGEYW	ANGPTL1	336	O95841
VYWAEFRGGSYSLKK	ANGPTL2	466	Q9UKU9
GEFWLGLKKIFYIVN	ANGPTL5	221	Q86XS5
KKWCVLEGGFLSYYE	ARAP2	921	Q8WZ64
YAVKGNQWVGYDDVK	CHI3L2	326	Q15782
GYYRVNYDKLGWKKL	LVRN	656	Q6Q4G3
NYFGEKVALYFVWLG	ANO9	181	A1A5B4
KEGKGYIDWNTLKYV	CALML6	121	Q8TD86
VKKFNDWLGNLPYEY	MPPED2	96	Q15777
EIGNQLYLFKDGKYW	MMP9	526	P14780
LYLFKDGKYWRFSEG	MMP9	531	P14780
GLEKDFYGYQIWFAI	OTOP3	556	Q7RTS5
QLYGLEKFWAFLKYS	LARP1	986	Q6PKG0
YYWIGGEATLDKKAC	FLII	546	Q13045
ADVIWQYGLLKKGYG	LANCL1	306	O43813
VEGKEWGSFYYSFKT	NPSR1	36	Q6W5P4
YWLFKASGSDIVKLY	EDRF1	421	Q3B7T1
FLYKQEKAVGDKVYW	FLYWCH1	131	Q4VC44
LWGLEFQKNKDYYII	EFNB2	121	P52799
AKYIDYWTFLKDAFG	EFHC2	731	Q5JST6
KVKYGNYAFVWDAAV	GRID2	731	O43424
KIFKETGYWNVTVYG	MYO10	1456	Q9HD67
DKYWKKNGGSILFYT	PRCP	76	P42785
ALDYDEGKIYWGDAK	LRP6	496	O75581
GNKLYYNFPWGKELI	POLG2	286	Q9UHN1
RKYFGEKIGLYFAWL	ANO1	321	Q5XXA6
EKIGLYFAWLGVYTQ	ANO1	326	Q5XXA6
TDNIIYVYKIGEDWG	IFT172	86	Q9UG01
YVYKIGEDWGDKKVI	IFT172	91	Q9UG01
DLYIVGDGKYGAWKN	GRIN3A	596	Q8TCU5
YALDYWSKGQLKALF	PANK3	336	Q9H999
DGYLVEKKKLGTYTW	OBSCN	546	Q5VST9
YALDYWSKGQLKALF	PANK2	536	Q9BZ23
WIYNFNIKGKEYGEE	DNAJC25	266	Q9H1X3
ENGWIKEKYGQLEEY	CCDC82	516	Q8N4S0
YYKDDVFIIGGWKNS	KLHL11	606	Q9NVR0
AGYDYKVLIWNLDVG	CORO2B	156	Q9UQ03
YAGGFDKIWDYKLLV	CDHR3	636	Q6ZTQ4
FVSGGDDYKIKVWNY	COPA	66	P53621
YLDGWNAIFSFGKKL	CYP27A1	271	Q02318
GNYWRGLYKLEKTFH	DNAH7	801	Q8WXX0
LYAGADVQKGKYWDT	ASB5	221	Q8WWX0
AIGKLYYDNEKCWFG	CRHR1	276	P34998
KLRWYFKLYDVDGNG	GUCA1A	91	P43080
GWLKTVDQYFYGIKN	MAN2B1	76	O00754
GEVIAGDWKSYQYLV	COQ5	271	Q5HYK3
EYKTYGERDWVAKKG	IL22RA1	56	Q8N6P7
YAPLGWSKKYEFGES	DYNC1H1	4196	Q14204
LYAQFKGIEKLYEWQ	HELQ	326	Q8TDG4
WKEYAKGDSRYILGD	EBP	101	Q15125
KKAFEWYGTYLELCG	METTL13	26	Q8N6R0
DLAKKYLWQGLFQLY	H6PD	36	O95479
KFGKIGWNVYYDFNE	DNAH10	4036	Q8IVF4
TDKDYLGQWLLIYFG	SCO1	151	O75880
YDYLNEWGSRFKKLA	CDH3	806	P22223
FFEIYGGKVYDLLNW	KIF2B	356	Q8N4N8
SGQLYGLEKFWAYLK	LARP1B	806	Q659C4
ATTGWGLLDYKTEKY	P2RX6	16	O15547
VYVVGWALLAKKGYQ	P2RX6	51	O15547
YANKGKEWVGYDNAI	OVGP1	321	Q12889
IYKYIEYRGAEKEWG	SLC12A5	651	Q9H2X9
FYKLGNETWKGVFIY	IZUMO3	91	Q5VZ72
YGKGYVVWQEVFDNK	HEXA	366	P06865
YLHGYDKEGNKLFWI	MOSPD2	96	Q8NHP6
YKKFWAGLQGLTIYF	STAP2	36	Q9UGK3
FWCYKGAIGKVYHAL	TMEM248	236	Q9NWD8
EKWGGNKTYTAYVDL	YARS1	281	P54577
LLKWVAYGFKVYFTN	SCN4A	1081	P35499
QKTFWYGILKGYVQG	SLC9C1	741	Q4G0N8
SDIYIKGWLYGLEKD	FER1L5	1746	A0AVI2
YGVEKDKWDKAALGY	HCLS1	161	P14317
LAKWYVNAKGYFEDV	PLD1	351	Q13393
GYLQQWLKAFVGAFK	NBEAL2	21	Q6ZNJ1
EDWEYYLSGKLFNKS	PROM1	536	O43490
WGYKDPLVNLINKYF	SCARB1	181	Q8WTV0
EKKSWLGYAQGYLLY	MYCBP2	411	O75592
FNEKGWNYILEKYDG	NAMPT	96	P43490
WVFKQLYDKGLVYRG	IARS1	161	P41252
GWEEAYTADGIKYFI	STXBP4	501	Q6ZWJ1
KGIYLWDVEGRKYFD	OAT	66	P04181
AKYKDGNQVWLYAGI	SETDB1	266	Q15047
QKYELGAALYIGWAA	CLDN5	156	O00501
KIKGSYDYWVGLSQD	CLEC9A	166	Q6UXN8
YIAEIYFRAWKKASG	NCAPG2	261	Q86XI2
KYGYWVIGLEEGVKC	TRIM5	396	Q9C035
KGTFDSKYGEYEWVH	RPF1	321	Q9H9Y2
YILDQGGLKIYVWKG	VIL1	286	P09327
IIWGAYDGKYEKTLY	WDR5B	66	Q86VZ2
EKGSYGAWYPLLKNI	UNC13C	2161	Q8NB66
AEGSAQYKKWYFELI	RYR3	651	Q15413
ELLGWYGYDKVELKD	SOBP	41	A7XYQ1
GELYYSIEKEGQRKW	TP53BP1	1566	Q12888
SAAQALKKGWLYYEA	PLEC	4506	Q15149
LKKGWLYYEAGQRFL	PLEC	4511	Q15149
ILGKNAALWEYEVYK	VPS41	421	P49754
DFKKCYGEILYRWGL	WDR59	861	Q6PJI9
EGNRYDGIYKVVKYW	UHRF1	551	Q96T88
VYSYFAQDLWPKQGK	ZNF98	86	A6NK75
FRGYDFYGLKDKTWD	PLEKHG7	256	Q6ZR37
AKPWYKEFLQLIGYS	SEMA3E	706	O15041
QSLGELVKGVYAKYW	PIEZO1	566	Q92508
GKDFKWYLIFNEYEI	ZNF732	201	B4DXR9
GKYGCVDYWVKAFLD	TXNIP	116	Q9H3M7
AYGYWFKAVTETTKG	SIGLEC10	56	Q96LC7
YLGKYWAIKLATNAA	CCT8	501	P50990
NGQLKWYEDYKRGNF	ZHX3	821	Q9H4I2
GWKTFYAVLKGTVLY	PSD3	811	Q9NYI0
DYFIWYKQESGKGPQ	TRAV13-2	51	A0A0B4J235
IEKQFLLYAYWIGLG	VMP1	106	Q96GC9
RGYEAKWIYITKGYE	LRRIQ3	251	A6PVS8
YKDEYNSFLKGIGWI	NEB	1436	P20929
LYKLGWEEALKKGYD	NEB	2271	P20929
GKLYSTILYKGAWEG	NEB	4451	P20929
YKEDLTWLKGIGCYA	NEB	5336	P20929